Abstract: The present invention relates to materials and methods for treatment of hepatitis C. More closely, the invention relates to human monoclonal antibodies against HCV E1 antigen, to a reagent comprising such antibodies, and to vaccine compositions comprising such antibodies. Furthermore, the invention relates to a method of treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention.
Type:
Grant
Filed:
July 6, 2007
Date of Patent:
November 23, 2010
Assignee:
Molecules of Man AB
Inventors:
Katarina Drakenberg, Mats A. A. Persson
Abstract: The present invention relates to materials and methods for treatment of hepatitis C. More closely, the invention relates to human monoclonal antibodies against HCV E1 antigen, to a reagent comprising such antibodies, and to vaccine compositions comprising such antibodies. Futhermore, the invention relates to a method of treating or preventing HCV infection by administration of a vaccine composition comprising the monoclonal antibodies of the invention.
Type:
Grant
Filed:
January 14, 2002
Date of Patent:
July 31, 2007
Assignee:
Molecules of Man AB
Inventors:
Katarina Drakenberg, Mats A. A. Persson